Thank you for following along. For updates from Dr. Bertagnolli about NCI and cancer research, please follow @NCIDirector.

🧵To learn more about multi-cancer early detection (MCED) tests, please check out NCI’s Q&A: https://t.co/peP6rlTXah #MIHealthSummit @NCIprevention

🧵Many multi-cancer early detection (MCED) tests in development are intended to simultaneously screen for multiple types of cancer in otherwise healthy people, as @NCICastle explains: https://t.co/dN0svodqry #MIHealthSummit

Multi-cancer early detection (MCED) tests are a promising approach to detecting cancer. However, researchers have much to learn about them. NCI is planning clinical trials to understand them better with cancer mortality being the endpoint. https://t.co/vg3gwdFZIO #MIHealthSummit

To date, NCI has invested nearly $1 billion in Moonshot funding, supporting over 240 research projects across more than 70 cancer science initiatives. That investment has led to important insights tied to the Moonshot’s key research priorities. #MIHealthSummit #CancerMoonshot

In February 2022, President Biden announced plans “to supercharge the Cancer Moonshot as a central effort of the Biden-Harris administration." #MIHealthSummit #CancerMoonshot

The Cancer Moonshot was “launched” in December 2016, when Congress passed the 21st Century Cures Act. The act authorized $1.8 billion in funding for the Cancer Moonshot over 7 years. #MIHealthSummit #CancerMoonshot

At the @MilkenInstitute summit, @NCIDirector stresses that making continued progress against cancer will require collaboration across disciplines and agencies, as well as contributions from patients and advocates. Everyone has a role to play. #MIHealthSummit